메뉴 건너뛰기




Volumn 99, Issue 6, 2006, Pages 565-566

Homocysteine and cardiovascular disease: Is HDL the link?

Author keywords

apoA I; Cardiovascular; HDL; Homocysteine

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE;

EID: 33748754354     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000243583.39694.1f     Document Type: Editorial
Times cited : (34)

References (21)
  • 1
    • 0017284939 scopus 로고
    • The pathogenesis of coronary artery disease. A possible role for methionine metabolism
    • Wilcken DE, Wilcken B. The pathogenesis of coronary artery disease. A possible role for methionine metabolism. J Clin Invest. 1976;57:1079-1082.
    • (1976) J Clin Invest , vol.57 , pp. 1079-1082
    • Wilcken, D.E.1    Wilcken, B.2
  • 4
    • 33645282568 scopus 로고    scopus 로고
    • Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease
    • Mikael LG, Genest J Jr, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ Res. 2006;98:564-571.
    • (2006) Circ Res , vol.98 , pp. 564-571
    • Mikael, L.G.1    Genest Jr., J.2    Rozen, R.3
  • 6
    • 0035048682 scopus 로고    scopus 로고
    • Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction
    • Qujeq D, Omran TS, Hosini L. Correlation between total homocysteine, low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in the serum of patients with myocardial infarction. Clin Biochem. 2001;34:97-101.
    • (2001) Clin Biochem , vol.34 , pp. 97-101
    • Qujeq, D.1    Omran, T.S.2    Hosini, L.3
  • 7
    • 0017384270 scopus 로고
    • High density lipoprotein as a protective factor against coronary heart disease
    • Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR. High density lipoprotein as a protective factor against coronary heart disease. Am J Med. 1977;62:707-714.
    • (1977) Am J Med , vol.62 , pp. 707-714
    • Gordon, T.1    Castelli, W.P.2    Hjortland, M.C.3    Kannel, W.B.4    Dawber, T.R.5
  • 8
    • 0023029454 scopus 로고
    • Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham study
    • Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham study. JAMA. 1986;256:2835-2838.
    • (1986) JAMA , vol.256 , pp. 2835-2838
    • Castelli, W.P.1    Garrison, R.J.2    Wilson, P.W.3    Abbott, R.D.4    Kalousdian, S.5    Kannel, W.B.6
  • 9
    • 0025322265 scopus 로고
    • Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
    • Badimon JJ, Badimon L, Fuster V. Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest. 1990;85:1234-1241.
    • (1990) J Clin Invest , vol.85 , pp. 1234-1241
    • Badimon, J.J.1    Badimon, L.2    Fuster, V.3
  • 10
    • 0025902231 scopus 로고
    • Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
    • Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 1991;353:265-267.
    • (1991) Nature , vol.353 , pp. 265-267
    • Rubin, E.M.1    Krauss, R.M.2    Spangler, E.A.3    Verstuyft, J.G.4    Clift, S.M.5
  • 13
    • 0030045883 scopus 로고    scopus 로고
    • High density lipoproteins and coronary heart disease
    • Barter PJ, Rye KA. High density lipoproteins and coronary heart disease. Atherosclerosis. 1996;121:1-12.
    • (1996) Atherosclerosis , vol.121 , pp. 1-12
    • Barter, P.J.1    Rye, K.A.2
  • 17
    • 0037164104 scopus 로고    scopus 로고
    • Homocysteine and risk of ischemic heart disease and stroke: A meta-analysis
    • Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015-2222.
    • (2002) JAMA , vol.288 , pp. 2015-2222
  • 18
    • 1342309318 scopus 로고    scopus 로고
    • Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: The Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial
    • Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC, Howard VJ, Sides EG, Wang CH, Stampfer M. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA. 2004;291:565-575.
    • (2004) JAMA , vol.291 , pp. 565-575
    • Toole, J.F.1    Malinow, M.R.2    Chambless, L.E.3    Spence, J.D.4    Pettigrew, L.C.5    Howard, V.J.6    Sides, E.G.7    Wang, C.H.8    Stampfer, M.9
  • 21
    • 33645777279 scopus 로고    scopus 로고
    • Homocysteine trials-clear outcomes for complex reasons
    • Loscalzo J. Homocysteine trials-clear outcomes for complex reasons. N Engl J Med. 2006;354:1629-1632.
    • (2006) N Engl J Med , vol.354 , pp. 1629-1632
    • Loscalzo, J.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.